You have 7 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

small molecule inhibitors

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Exploratory Drug Interaction Study Between SMIs and DOACs

Recruiting
  • Solid Tumor
  • Cancer, Lung
    • Nijmegen, Gelderland, Netherlands
    • +1 more
    Feb 7, 2023

    Locally Advanced or Recurrent/Metastatic Salivary Gland Carcinoma, Neoadjuvant or Conversion Therapy, Precision Therapy Trial in

    Recruiting
    • Locally Advanced or Recurrent/Metastatic Salivary Gland Carcinoma
    • +2 more
    • Beijing, Beijing, China
    • +1 more
    Nov 21, 2023

    Nutrition, Healthy Trial in Re?ovot (nutritional)

    Recruiting
    • Nutrition, Healthy
    • nutritional
    • Reẖovot, Israel
      Weizmann Institute of Science
    Jul 16, 2023

    Neurodegenerative Diseases Trial (SMARTO ONE, )

    Not yet recruiting
    • Neurodegenerative Diseases
    • SMARTO ONE
    • placebo
    • (no location specified)
    Jul 14, 2023

    Neurodegenerative Diseases Trial (SMARTO ONE)

    Not yet recruiting
    • Neurodegenerative Diseases
    • SMARTO ONE
    • (no location specified)
    Jul 14, 2023

    Breast Cancer Trial in Guangzhou (Take probiotics)

    Recruiting
    • Breast Cancer
    • Take probiotics
    • Guangzhou, Guangdong, China
      Sun Yat-sen University Cancer Center
    Mar 6, 2023

    Retinitis Pigmentosa Trial (KIO-301)

    Recruiting
    • Retinitis Pigmentosa
    • Adelaide, South Australia, Australia
      Royal Adeliade Hospital
    Dec 22, 2022

    Small Molecule LCDM and GV Oocyte

    Not yet recruiting
    • Assisted Reproduction
    • Small molecule LCDM
    • (no location specified)
    Apr 26, 2022

    Clear Cell Renal Cell Carcinoma Trial in Beijing (68Ga-NY104)

    Completed
    • Clear Cell Renal Cell Carcinoma
    • Beijing, Beijing, China
      Peking Union Medical College Hospital
    Feb 6, 2023

    Biologics or Small Molecule Therapies in Inflammatory Bowel

    Completed
    • Crohn's Disease
    • Ulcerative Colitis
      • New York, New York
      • +1 more
      Jan 9, 2023

      HRD Cancer, SCLC, Advanced Solid Tumors Trial run by the NCI (Berzosertib, Sacituzumab Govitecan)

      Recruiting
      • HRD Cancer
      • +2 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Jan 20, 2023

      Non Small Cell Lung Cancer Recurrent Trial (Toripalimab, Anlotinib and Chemotherapy)

      Not yet recruiting
      • Non Small Cell Lung Cancer Recurrent
      • Toripalimab, Anlotinib and Chemotherapy
      • (no location specified)
      Apr 24, 2023

      Gastroesophageal Reflux, Regurgitation, Heartburn Trial in Jacksonville (Breath Testing)

      Not yet recruiting
      • Gastroesophageal Reflux
      • +2 more
      • Breath Testing
      • Jacksonville, Florida
        Mayo Clinic Florida
      Jul 27, 2023

      ICIs Plus Angiogenesis Inhibitors for Treatment of Advanced

      Completed
      • NSCLC
      • Immune checkpoint inhibitors plus angiogenesis inhibitors
      • Immune checkpoint inhibitors without angiogenesis inhibitors
      • Suzhou, Jiangsu, China
        The Affiliated Suzhou Hospital of Nanjing Medical University
      Jan 17, 2023

      NSCLC With EGFR Mutation Trial in Mexico City (Glutamine plus L. reuteri)

      Recruiting
      • Non-Small Cell Lung Cancer With EGFR Mutation
      • Glutamine plus L. reuteri
      • Mexico City, Mexico
        Instituto Nacional de Cancerologia de Mexico
      May 2, 2023

      Immune Checkpoint Inhibitors in Non-Small Cell Lung Carcinoma

      Active, not recruiting
      • Non Small Cell Lung Cancer
      • Immune signature in serum associated to the metabolic signature
      • Meta-genomic signature of intestinal flora
      • La Tronche, Isère, France
        University Hospital, Grenoble
      Jan 6, 2023

      Non Small Cell Lung Cancer Trial in Brussels (FAPI PET/CT)

      Recruiting
      • Non Small Cell Lung Cancer
      • FAPI PET/CT
      • Brussels, Belgium
        Institut Jules Bordet
      Oct 24, 2023

      Combined Statin and PD-1/PD-L1 Inhibitors in Treating Non-small

      Recruiting
      • Lung Cancer
      • Yiwu, Zhejiang, China
        The Fourth Affiliated Hospital of Zhejiang University
      Dec 16, 2022

      Non Small Cell Lung Cancer, Liquid Biopsy, Tyrosine Kinase Inhibitor Trial in Rotterdam

      Recruiting
      • Non Small Cell Lung Cancer
      • +2 more
        • Rotterdam, Netherlands
          Erasmus MC
        Feb 2, 2022

        NSCLC Stage III Trial (radiotherapy, Platinum-Based Drug, Immunotherapy)

        Not yet recruiting
        • Non-small Cell Lung Cancer Stage III
        • radiotherapy
        • +3 more
        • (no location specified)
        Sep 10, 2023

        NSCLC, Low Dose Radiotherapy, Stereotactic Body Radiotherapy Trial in Chengdu (Low Dose Radiotherapy, stereotactic body

        Not yet recruiting
        • NSCLC
        • +3 more
        • Low Dose Radiotherapy
        • +2 more
        • Chengdu, Sichuan, China
          West China Hospital, Sichuan University
        Nov 11, 2022

        NSCLC Trial in United States (brigatinib)

        Terminated
        Has Results
        • Non-Small Cell Lung Cancer
        • Denver, Colorado
        • +3 more
        Jan 10, 2023

        NSCLC, Metastatic Lung Non-Small Cell Carcinoma, Non Small Cell Lung Cancer Trial (Palliative Radiotherapy: 5 x 4Gy, chemo +

        Not yet recruiting
        • Carcinoma, Non-Small-Cell Lung
        • +2 more
        • Palliative Radiotherapy: 5 x 4Gy
        • chemotherapy + immune checkpoint inhibitors
        • (no location specified)
        Jun 27, 2022

        Immune Checkpoint Inhibitors Nephrotoxicity

        Recruiting
        • Kidney Injury
        • Antineoplastics Toxicity
        • Early kidney damage biomarkers
        • Predisposition to kidney injury biomarkers
        • Salamanca, Spain
        • +1 more
        Jul 26, 2022

        Radiotherapy Combined With PD-1 Inhibitors and Chemotherapy in

        Recruiting
        • Non-small Cell Lung Cancer Metastatic
        • Brain Metastases
        • Radiotherapy combined with PD-1 inhibitors
        • Changsha, Hunan, China
          Xiangya Hospital, Central South University
        Nov 27, 2022